- Home
- PCAR vs TAK Comparison
PCAR vs TAK Comparison
Compare PCAR & TAK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PCAR
- TAK
- Stock Information
- Founded
- PCAR 1905
- TAK 1781
- Country
- PCAR United States
- TAK Japan
- Employees
- PCAR N/A
- TAK N/A
- Industry
- PCAR Auto Manufacturing
- TAK Biotechnology: Pharmaceutical Preparations
- Sector
- PCAR Consumer Discretionary
- TAK Health Care
- Exchange
- PCAR Nasdaq
- TAK Nasdaq
- Market Cap
- PCAR 52.6B
- TAK 47.3B
- IPO Year
- PCAR N/A
- TAK N/A
- Fundamental
- Price
- PCAR $98.21
- TAK $13.77
- Analyst Decision
- PCAR Hold
- TAK
- Analyst Count
- PCAR 10
- TAK 0
- Target Price
- PCAR $107.44
- TAK N/A
- AVG Volume (30 Days)
- PCAR 3.0M
- TAK 2.7M
- Earning Date
- PCAR 10-21-2025
- TAK 10-30-2025
- Dividend Yield
- PCAR 4.36%
- TAK 3.94%
- EPS Growth
- PCAR N/A
- TAK N/A
- EPS
- PCAR 5.10
- TAK 0.59
- Revenue
- PCAR $29,531,500,000.00
- TAK $31,053,301,865.00
- Revenue This Year
- PCAR N/A
- TAK $0.14
- Revenue Next Year
- PCAR $4.74
- TAK $0.58
- P/E Ratio
- PCAR $19.26
- TAK $23.29
- Revenue Growth
- PCAR N/A
- TAK 1.52
- 52 Week Low
- PCAR $84.65
- TAK $12.80
- 52 Week High
- PCAR $118.81
- TAK $15.69
- Technical
- Relative Strength Index (RSI)
- PCAR 50.77
- TAK 33.65
- Support Level
- PCAR $98.25
- TAK $13.99
- Resistance Level
- PCAR $101.29
- TAK $14.23
- Average True Range (ATR)
- PCAR 2.56
- TAK 0.12
- MACD
- PCAR 0.42
- TAK 0.02
- Stochastic Oscillator
- PCAR 58.63
- TAK 18.02
About PCAR PACCAR Inc.
Paccar is a leading manufacturer of medium- and heavy-duty trucks under the premium nameplates Kenworth and Peterbilt, which are primarily sold in the Americas and Australia, and DAF, which primarily services Europe and South America. The trucks segment (74% sales) goes to market through a network of 2,200 independent dealers. Paccar maintains an internal finance subsidiary that provides retail and wholesale financing for customers and dealers (6% sales). In recent years, Paccar has aggressively grown its parts business (20% sales), which include engines, axles, and transmissions for its own truck brands as well as independent producers. The company commands approximately 30% of the Class 8 market share in North America and 15% of the heavy-duty market share in Europe.
About TAK Takeda Pharmaceutical Company Limited (each representing 1/2 of a share of)
Takeda Pharmaceutical is Japan's largest pharmaceutical company, with revenue of JPY 4.6 trillion in fiscal 2024. The company's five core therapeutic areas are oncology, gastroenterology, neuroscience, rare diseases, and plasma-derived therapies, which account for more than 80% of revenue. Its geographic footprint is well diversified, with over 50% derived from the US, 20% from Japan, 20% from Europe and Canada.